Paige A. Taylor, PhD, MS

To assess different proton beam arrangements’ robustness for planning stereotactic body proton therapy (SBPT) to the liver.

IROC and Radiation Quality Assurance Lab monitor more than 2500 radiotherapy facilities worldwide to ensure accurate and consistent radiotherapy delivery. This study reviews the 30 year history of the anthropomorphic phantom program for advanced photon therap...

While adaptive radiotherapy (ART) is increasingly being adopted into clinical practice, treatment planning, delivery, dose reporting, and clinical trial QA have not yet been standardized for national clinical trials, leaving a gap in ensuring consistent and p...

The IROC SRS brain phantom provides independent end-to-end tests for clinical trial credentialing; utilizing this unique dataset characterized by heterogeneous community practices, we aimed to evaluate the utility of machine learning in predicting audit outco...

The Imaging and Radiation Oncology Core (IROC) IMRT head and neck (HN) phantom continues to show unacceptable delivery rates at ~10%. Increased understanding of what drives performance on this audit would assist in targeted improvement of radiotherapy quality...

In radiation oncology, advanced imaging tools such as dual-energy computed tomography (DECT) offer the potential for improved tumor delineation and reduced proton range uncertainty. Such technologies are often introduced into clinical workflows without compre...

To identify and consolidate contemporary dosimetric performance data for Elekta linear accelerators including specialized beams such as flattening-filter free (FFF) beams, which were not included in the original IROC reference dosimetry dataset.

Professional

Therapy Physics

To design and validate a phantom capable of remote temporal and point dose rate assessment for electron and proton FLASH beams, with integrated spatial information to enable full end to end verification.

A clear link has been established between exposure to neutron-producing therapies and cardiac implantable electronic device (CIED) malfunction. However, the risk of neutron-induced CIED malfunction under specific clinical conditions has yet to be elucidated....

To characterize TLD-100 (LiF:Mg,Ti) detector response to synchrotron-based therapeutic proton beams across in-pulse dose rates spanning 0.1 to 2,000 Gy/s.